Genetic variation of matrix metalloproteinase enzyme in HIV-associated neurocognitive disorder

Area of Science:

• Biochemistry
• Immunology
• Neuroscience

Background:

• Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix remodeling, essential for physiological processes like wound healing and development.
• MMPs are endogenously inhibited by tissue inhibitors of metalloproteinases (TIMPs).
• Dysregulation of MMPs is implicated in numerous diseases, including rheumatoid arthritis, cancer, and neurodegenerative disorders.

Purpose of the Study:

• To review the gene expression of MMPs in HIV-related diseases.
• To investigate the potential association of TIMPs and MMPs with HIV disease progression, vulnerability, and HIV-associated neurological diseases (HAND).

Main Methods:

• Review of existing literature on MMP and TIMP classification, regulation, and gene polymorphisms.
• Analysis of studies examining the impact of MMP and TIMP gene expression and polymorphisms on HIV-associated diseases.

Main Results:

• MMPs play a critical role in extracellular matrix degradation, facilitating viral dissemination and contributing to disease pathogenesis.
• Specific MMP gene polymorphisms (MMP-1, MMP-2, MMP-3, and MMP-9) have been associated with increased HIV vulnerability, disease progression, and HAND.
• MMPs act as a crucial interface between HIV-1 Tat protein and the extracellular matrix, compromising endothelial barriers.

Conclusions:

• MMPs and TIMPs are significantly involved in the pathogenesis of HIV-related diseases.
• MMP gene expression and polymorphisms are key factors influencing HIV vulnerability, disease progression, and the development of HAND.
• Further research into the role of MMPs and TIMPs in HIV pathogenesis and their therapeutic potential is warranted.